You don't have to be a financial wizard to glean the most important statistics about a prospective stock investment. Read More
John Persinos is the editorial director of Investing Daily, overseeing such publications as Personal Finance, Utility Forecaster, Profit Catalyst Alert, Rapier's Income Accelerator, Income Forecaster, and Marijuana Investing Daily, among others. John also writes the Mind Over Markets daily stock market recap, and he's the chief investment strategist of Marijuana Profit Alert.
John has decades of experience in the technology and political realms. He has worked as a staff editor at Inc. and Venture magazines, and written for Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, to name a few. In a career that has spanned more than 40 years, John has been diligently and prolifically covering the news and its impact on investors.
John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan (D-ND). John started his career as a daily newspaperman with The Orlando Sentinel.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
Here's a manual for achieving steady, reliable gains with more peace of mind. Read More
As solar energy flourishes, investors can bask in sunny profits from these two industry standouts. Read More
This Argentina-based company is putting Latin American e-commerce onto the map. Read More
America’s new health reform law will generate reams of paperwork, boosting long-term growth for this UK-based outsourcing giant. Read More
This China-based technology company dominates online gaming, a phenomenon that’s sweeping the Middle Kingdom. Read More
Aircraft maker Boeing is positioned for soaring growth, after reaping a windfall of orders at the Paris Air Show. Read More
Catastrophe and upheaval around the globe are boosting demand for this undervalued crisis management company. Read More
This Israel-based drug company combines groundbreaking innovation with large-cap stability, as it pursues new and lucrative avenues of cancer treatment. Read More
Helicopter ambulances represent a big and growing business. Here’s the best investment play on these airborne medical miracles. Read More